GlycoQuest: an AI-powered CGM game for kids with type 1 diabetes and their families
Official title: GlycoQuest: Glycemic and Psychosocial Outcomes of a CGM-Integrated, AI-Adaptive Serious Game Digital Therapeutic in Newly Diagnosed Pediatric Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial
Run by Shifa International Hospital · NCT07726680 · Data updated 2026-11-12
A CGM-linked, AI-adaptive serious game is tested with children 6-17 who have type 1 diabetes and their primary caregivers to see if it helps with glucose control and coping in the first year after diagnosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 17 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Shifa International Hospital Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | November 1, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07726680 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 6-17 with a recent type 1 diabetes diagnosis (within 3 months) and a willing primary caregiver, who currently use or will start CGM and have access to a compatible device.
✕Probably not a fit
Children without CGM access or with conditions preventing engagement in a digital therapeutic may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial tests GlycoQuest, a digital therapeutic that blends continuous glucose monitoring data with an adaptive, child-facing game and parent–child collaboration. The game uses real-time glucose patterns to tailor learning pathways and in-game scenarios, aiming to improve self-management skills and reduce diabetes distress. The study also includes psychosocial content addressing fear of hypoglycemia, stigma, illness acceptance, and family communication, along with practical modules on insulin safety and carbohydrate estimation. Participants are children with recent type 1 diabetes diagnosis (within 3 months) and their primary caregivers, who will engage with the CGM-linked platform over the first year after diagnosis. The primary question is whether this personalized digital intervention can improve glycemic outcomes and family functioning compared with standard education alone.
Why it matters
Potential benefit: If successful, the intervention could improve time-in-range and reduce diabetes distress for patients and families during the critical first year after diagnosis.
How similar studies have gone: Previous digital therapeutics in pediatric diabetes have shown promise in improving engagement and knowledge, though AI-adaptive CGM-linked gaming is relatively novel and evidence is emerging.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child or adolescent aged 6 to 17 years at enrollment. * Diagnosis of type 1 diabetes confirmed by a pediatric endocrinologist according to standard clinical criteria. * Type 1 diabetes diagnosed within the previous 3 months. * Primary caregiver aged 18 years or older willing to participate as part of a parent-child dyad. * Current use of continuous glucose monitoring or willingness to initiate CGM as part of standard diabetes care. * Household access to a compatible smartphone or tablet, or willingness to use a study-provided device if available. * Ability of child and caregiver to engage with study procedures and digital intervention content. * Caregiver able to provide written informed consent. * Child able to provide age-appropriate assent. Exclusion Criteria: * Type 1 diabetes diagnosed more than 3 months before enrollment. * Concurrent participation in another intensive diabetes behavioral intervention trial. * Significant developmental, intellectual, visual, motor, or psychiatric condition that, in the opinion of the clinical team, would preclude meaningful engagement with the digital game interface or study procedures. * Acute psychiatric instability or safety concern requiring urgent specialist intervention. * Planned transfer to a different diabetes care provider within 6 months. * Absence of internet access that cannot be addressed by study support.
Where it's running
-
Shifa International hospital
Lahore, Punjab Province, Pakistan Recruiting
Study contacts
- Study coordinator: Nadia Hussain, MD, PhD
- Email: nadia.hussain@aau.ac.ae
- Phone: 0505440153
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Environmental factors and Type 1 diabetes risk in China
This observation study tests how environmental factors may influence Type 1 diabetes risk in China, including patients, healthy controls, and relatives.
-
Drawing and Writing Activities for Teens with Type 1 Diabetes
This trial tests whether a five-day online drawing and writing program can reduce anxiety and affect in adolescents with type 1 diabetes.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Pediatric Insulin Dose Calculator to Help Manage Type 1 Diabetes in Under-12s
A digital tool that helps caregivers of children under 12 with Type 1 diabetes calculate insulin doses during meals, tested alongside standard care for 6 months.
-
Using regular client feedback (FIT) to improve outcomes in social services
This project will test whether using regular client feedback with FIT helps people receiving social services—such as outpatient, addiction, and residential care—get better, more tailored support.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.